Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Point-of-Care Testing: Page 5
QuidelOrtho shares rise on preliminary Q1 revenues
By
LabPulse.com staff writers
Non-respiratory product revenue is expected to be $578 million to $583 million, representing 7% year-over-year growth on a constant currency basis at the midpoint.
April 14, 2023
LumiraDx to lay off about 40% of workforce in cost restructuring
By
Leo O'Connor
The changes are driven in part by reduced production due to lower demand for COVID-19 testing, as well as a focus on streamlining operations in commercial and R&D activities while preserving core functions for revenue generation.
April 6, 2023
Immunexpress to present data on host-response sepsis test at ECCMID 2023
By
LabPulse.com staff writers
The firm's SeptiCyte Rapid molecular test for sepsis uses reverse transcription polymerase chain reaction to quantify the relative expression levels of host-response genes isolated from whole blood.
April 5, 2023
Labcorp, Conference of National Black Churches to distribute screening kits for those at higher risk of colon cancer
By
LabPulse.com staff writers
Under the partnership, the Conference of National Black Churches will distribute more than 3,000 colorectal screening test kits in several urban and rural locations including Atlanta, Dallas, Memphis, Washington, DC, New Haven, Los Angeles, and Richmond.
April 3, 2023
Mars to acquire veterinary diagnostics firm Heska for $120 per share
By
LabPulse.com staff writers
The transaction price represents a premium of approximately 23% over Heska's closing stock price on March 31, and the deal has been approved by the boards of directors of both companies.
April 3, 2023
Swedish IVD market estimated at $804 million in 2022: Kalorama Information
By
Bruce Carlson
Critical care point-of-care tests, used for assessment of emergency room (ER) and intensive care unit (ICU) patients in hospitals or ambulatory settings, are expected to grow about three times faster in Sweden than in the U.S. over the next five years.
March 31, 2023
Ad Astra Diagnostics files FDA 510(k) application for point-of-care hematology analyzer
By
LabPulse.com staff writers
The QScout hematology platform is a rapid testing system that would operate at the point of care to provide measurements indicative of disease and infection, including sepsis.
March 30, 2023
Hemex Health nabs $3M NIH grant to develop portable test for sickle cell disease
By
LabPulse.com staff writers
According to Hemex, the test is being developed to be affordable, portable, and usable at the point of care, providing results in about eight minutes.
March 29, 2023
Frequent COVID-19 testing of nursing home staff saved lives: Study
By
Elissa Wolfson
Nursing homes that conducted frequent staff surveillance testing from 2020 to 2022 experienced significantly lower COVID-19 cases and deaths among residents.
March 23, 2023
Quest Diagnostics offers suite of services for transplant patients and living donors
By
LabPulse.com staff writers
The offerings of the Quest Advanced Specialized Transplant Services suite include access to Quest’s national network of service centers and mobile phlebotomists for both recipients and living donors in the 48 contiguous U.S. states.
March 23, 2023
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
By
LabPulse.com staff writers
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Patients prefer immediate test results, even when the news is bad
By
Elissa Wolfson
In a recent survey, patients overwhelmingly preferred receiving their test results immediately, even if their provider had not yet reviewed them.
March 21, 2023
Previous Page
Page 5 of 41
Next Page